Genentech Announces FDA Approval of Xofluza(Baloxavir Marboxil) to Treat Influenza in Children Aged Five and Older
Summary: Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved for children as young…
Summary: Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved for children as young…
The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as GlaxoSmithKline turns…